🇺🇸 FDA
Patent

US 8226977

Pharmaceutical composition containing irbesartan

granted A61KA61K31/4184A61K31/54

Quick answer

US patent 8226977 (Pharmaceutical composition containing irbesartan) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K31/4184, A61K31/54, A61K9/2027, A61K9/2031